Pages that link to "Q48473266"

The following pages link to Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides (Q48473266):

Displaying 40 items.

• Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss (Q22337080) (← links)
• A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ (Q24627359) (← links)
• Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation (Q28506810) (← links)
• PolyADP-ribosylation is involved in neurotrophic activity (Q28567748) (← links)
• Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures (Q28572910) (← links)
• NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42) (Q33393912) (← links)
• Amyloid beta peptide membrane perturbation is the basis for its biological effects (Q33790830) (← links)
• A new concept in the pharmacology of neuroprotection (Q33942981) (← links)
• Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. (Q33956027) (← links)
• Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease (Q34064026) (← links)
• Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis (Q34276055) (← links)
• Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity (Q35168601) (← links)
• Neuroprotective peptide ADNF-9 in fetal brain of C57BL/6 mice exposed prenatally to alcohol (Q35548667) (← links)
• Activity-dependent neurotrophic factor-derived peptide prevents alcohol-induced apoptosis, in part, through Bcl2 and c-Jun N-terminal kinase signaling pathways in fetal brain of C57BL/6 mouse (Q35714100) (← links)
• Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse (Q36422348) (← links)
• NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). (Q36449219) (← links)
• Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse (Q36501608) (← links)
• Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin. (Q36829280) (← links)
• Experimental methods for testing the effects of neurotrophic peptide, ADNF-9, against alcohol-induced apoptosis during pregnancy in c57bl/6 mice (Q36886815) (← links)
• Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease (Q36940103) (← links)
• VIP, from gene to behavior and back: summarizing my 25 years of research (Q37209639) (← links)
• A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice: signaling pathway investigations. (Q37441352) (← links)
• Microtubule stabilising peptides rescue tau phenotypes in-vivo (Q37464820) (← links)
• D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy. (Q38041481) (← links)
• Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides (Q39008879) (← links)
• Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro (Q40355185) (← links)
• VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress (Q40812665) (← links)
• A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth (Q45085034) (← links)
• Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium. (Q45934778) (← links)
• Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. (Q46628267) (← links)
• Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL. (Q48543647) (← links)
• Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. (Q48793040) (← links)
• VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury (Q48916561) (← links)
• D-SAL and NAP: Two Peptides Sharing a SIP Domain (Q48946832) (← links)
• Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory (Q48968128) (← links)
• A glia-derived signal regulating neuronal differentiation. (Q52163762) (← links)
• Quantitative analysis of streptococcal exoprotein flow to the host receptor--exact basis for therapy of tumors and Alzheimer's disease. (Q53270209) (← links)
• ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect. (Q55255816) (← links)
• Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity (Q73484920) (← links)
• VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects (Q93013712) (← links)